BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36001917)

  • 1. COVID-19 booster uptake among US adults: Assessing the impact of vaccine attributes, incentives, and context in a choice-based experiment.
    Raman S; Kriner D; Ziebarth N; Simon K; Kreps S
    Soc Sci Med; 2022 Oct; 310():115277. PubMed ID: 36001917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated With Marshallese and Hispanic Adults' Willingness to Receive a COVID-19 Booster Dose.
    Purvis RS; Vincenzo JL; Spear M; Moore R; Patton SK; Callaghan-Koru J; McElfish PA; Curran GM
    J Prim Care Community Health; 2023; 14():21501319231171440. PubMed ID: 37191303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, Usability, and Acceptability of a Chatbot for Promoting COVID-19 Vaccination in Unvaccinated or Booster-Hesitant Young Adults: Pre-Post Pilot Study.
    Luk TT; Lui JHT; Wang MP
    J Med Internet Res; 2022 Oct; 24(10):e39063. PubMed ID: 36179132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Analysis of the Willingness to the COVID-19 Vaccine Booster Shots among Urban Employees: Evidence from a Megacity H in Eastern China.
    Hu T; Li L; Lin C; Yang Z; Chow C; Lu Z; You C
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated With US Adults' Likelihood of Accepting COVID-19 Vaccination.
    Kreps S; Prasad S; Brownstein JS; Hswen Y; Garibaldi BT; Zhang B; Kriner DL
    JAMA Netw Open; 2020 Oct; 3(10):e2025594. PubMed ID: 33079199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on the factors influencing the intention to receive booster shots of the COVID-19 vaccine in China based on the information frame effect.
    Zhu Q; Gao Y; Hu Q; Hu D; Wu X
    Front Public Health; 2024; 12():1258188. PubMed ID: 38444439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influences on COVID-19 booster uptake among adults intending to receive a booster: a qualitative study.
    Moore R; Purvis RS; Willis DE; Li J; Selig JP; Ross J; McElfish PA
    Health Promot Int; 2024 Jun; 39(3):. PubMed ID: 38902983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jordanians' willingness to receive heterologous prime-boost COVID-19 vaccination and vaccine boosters.
    Rababa'h AM; Abedalqader NN; Ababneh M
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7516-7525. PubMed ID: 34919254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preference and Willingness to Pay for the Regular COVID-19 Booster Shot in the Vietnamese Population: Theory-Driven Discrete Choice Experiment.
    Tran BX; Do AL; Boyer L; Auquier P; Le HT; Le Vu MN; Dang THT; Cao KM; Le LDT; Cu LTN; Ly BV; Nguyen DAT; Nguyen MD; Latkin CA; Ho RCM; Ho CSH; Zhang MWB
    JMIR Public Health Surveill; 2023 Jan; 9():e43055. PubMed ID: 36599156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Correlates & Public Health Consequences of Prospective Vaccine Hesitancy among Individuals Who Received COVID-19 Vaccine Boosters in the U.S.
    Motta M
    Vaccines (Basel); 2022 Oct; 10(11):. PubMed ID: 36366300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willingness to accept a second COVID-19 vaccination booster dose among healthcare workers in Italy.
    Della Polla G; Miraglia Del Giudice G; Folcarelli L; Napoli A; Angelillo IF;
    Front Public Health; 2022; 10():1051035. PubMed ID: 36568799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021.
    Johnson AG; Amin AB; Ali AR; Hoots B; Cadwell BL; Arora S; Avoundjian T; Awofeso AO; Barnes J; Bayoumi NS; Busen K; Chang C; Cima M; Crockett M; Cronquist A; Davidson S; Davis E; Delgadillo J; Dorabawila V; Drenzek C; Eisenstein L; Fast HE; Gent A; Hand J; Hoefer D; Holtzman C; Jara A; Jones A; Kamal-Ahmed I; Kangas S; Kanishka F; Kaur R; Khan S; King J; Kirkendall S; Klioueva A; Kocharian A; Kwon FY; Logan J; Lyons BC; Lyons S; May A; McCormick D; ; Mendoza E; Milroy L; O'Donnell A; Pike M; Pogosjans S; Saupe A; Sell J; Smith E; Sosin DM; Stanislawski E; Steele MK; Stephenson M; Stout A; Strand K; Tilakaratne BP; Turner K; Vest H; Warner S; Wiedeman C; Zaldivar A; Silk BJ; Scobie HM
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):132-138. PubMed ID: 35085223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: A systematic review.
    Chenchula S; Karunakaran P; Sharma S; Chavan M
    J Med Virol; 2022 Jul; 94(7):2969-2976. PubMed ID: 35246846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review.
    Külper-Schiek W; Piechotta V; Pilic A; Batke M; Dreveton LS; Geurts B; Koch J; Köppe S; Treskova M; Vygen-Bonnet S; Waize M; Wichmann O; Harder T
    Front Immunol; 2022; 13():940562. PubMed ID: 36091023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness and Perceptions Regarding COVID-19 Vaccine Booster Dose in Pakistani Vaccinated Population: A Cross-Sectional Survey.
    Moeed A; Najeeb H; Saleem A; Asghar MS; Rafi HM; Khattak AK; Bilal Z; Seboka BT
    Front Public Health; 2022; 10():911518. PubMed ID: 35844859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Interventions for COVID-19 Primary and Booster Vaccination? Effects of Psychological Factors and Health Policies on Vaccine Uptake.
    Sprengholz P; Henkel L; Böhm R; Betsch C
    Med Decis Making; 2023 Feb; 43(2):239-251. PubMed ID: 36404766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
    Thompson MG; Natarajan K; Irving SA; Rowley EA; Griggs EP; Gaglani M; Klein NP; Grannis SJ; DeSilva MB; Stenehjem E; Reese SE; Dickerson M; Naleway AL; Han J; Konatham D; McEvoy C; Rao S; Dixon BE; Dascomb K; Lewis N; Levy ME; Patel P; Liao IC; Kharbanda AB; Barron MA; Fadel WF; Grisel N; Goddard K; Yang DH; Wondimu MH; Murthy K; Valvi NR; Arndorfer J; Fireman B; Dunne MM; Embi P; Azziz-Baumgartner E; Zerbo O; Bozio CH; Reynolds S; Ferdinands J; Williams J; Link-Gelles R; Schrag SJ; Verani JR; Ball S; Ong TC
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):139-145. PubMed ID: 35085224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.